Form 4: Organogenesis Holdings Inc. Insiders Transfer Shares for Estate Planning

A group of Organogenesis Holdings Inc. insiders, including Alan A. Ades, transferred shares to his spouse for estate planning purposes, with no change to the total number of securities held by the group.

Summary

• Alan A. Ades, a director and 10% owner of Organogenesis Holdings Inc., transferred 1,710,552 shares of Class A Common Stock to his spouse, Josette Ades, on December 31, 2024.
• The transfer was a gift for no consideration and was done for estate planning purposes.
• This transaction did not change the total number of shares held by the group of insiders, which includes Alan A. Ades, Josette Ades, and several other individuals and entities.
• The group is party to a Controlling Stockholders' Agreement that provides for nomination rights of four directors of the Issuer.
• The group may be deemed to hold over 10% of the outstanding shares of common stock of the issuer.

Sentiment

Score: 7

Explanation: The document reflects a neutral event, a routine share transfer for estate planning purposes. There is no indication of positive or negative sentiment towards the company's performance or future prospects.

Positives

• The transfer is for estate planning purposes, which is a common practice for individuals with significant holdings.
• The total number of shares held by the group remains unchanged, indicating no reduction in their overall stake.

Risks

• While the transfer is for estate planning, any future changes in ownership within the group could potentially impact the company's governance.
• The group's significant holdings and control could pose a risk if their interests diverge from other shareholders.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. The transfer is for estate planning purposes and does not indicate any change in the group's overall investment strategy or outlook for the company.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with regulatory requirements.
• The transfer of shares for estate planning purposes is a common practice among high-net-worth individuals and is not unusual in the context of corporate governance.

Related Party Transactions

• The transfer of shares between Alan A. Ades and his spouse, Josette Ades, is a related party transaction.

Stakeholder Impact

• The share transfer has no immediate impact on shareholders as the total number of shares held by the group remains unchanged.
• The transfer is unlikely to impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Organogenesis Holdings Inc., insider trading, share transfer, estate planning, beneficial ownership, Form 4, controlling stockholders, group ownership